Unlocking Value: The Piotroski-Graham Strategy for Outperformance

Morgan Housel

Award-winning financial writer and partner at The Collaborative Fund, exploring the psychology of money.

The landscape of investment strategies is constantly evolving, yet the timeless principles of value investing, championed by figures like Benjamin Graham, continue to yield remarkable results. A notable approach, the Piotroski-Graham Enhanced Value strategy, has demonstrated exceptional performance, significantly outperforming the broader market. This method meticulously selects stocks based on stringent financial health indicators and undervaluation metrics, proving its resilience and profitability over time.

Central to this strategy are the Piotroski F-Scores, which assess a company's financial strength, and the Graham Number, which identifies deeply discounted stocks. By integrating the Beneish M-Score, the strategy also scrutinizes for potential earnings manipulation, ensuring a robust selection of companies with both intrinsic value and transparent financial practices. Examples such as EXE and MOMO illustrate the strategy's effectiveness, showcasing companies trading at substantial discounts to their intrinsic value, supported by strong fundamentals and favorable market conditions. Furthermore, the inclusion of Momentum Gauge signals provides an additional layer of optimization, allowing investors to navigate market cycles more effectively, enhance returns, and reduce potential drawdowns, particularly in volatile periods or when growth stocks dominate the narrative.

In a market often captivated by high-growth narratives, a strategic shift towards value stocks could be imminent. Macroeconomic developments and technical indicators suggest a potential rotation, positioning carefully selected value companies for sustained growth. By adhering to a disciplined, data-driven approach that blends foundational value principles with contemporary analytical tools, investors can uncover opportunities that promise long-term outperformance and foster financial well-being.

you may like

youmaylikeicon
Douglas Dynamics: A Promising Small-Cap Industrial Stock with Strong Growth Potential

Douglas Dynamics: A Promising Small-Cap Industrial Stock with Strong Growth Potential

By David Rubenstein
Western Asset Total Return Unconstrained Fund's Q1 2026 Performance Analysis Amid Geopolitical Shifts and AI Disruption

Western Asset Total Return Unconstrained Fund's Q1 2026 Performance Analysis Amid Geopolitical Shifts and AI Disruption

By Lisa Jing
Capstone Energy+: A Shift Towards Ultra-Clean, Modular, and Hybrid Energy Solutions

Capstone Energy+: A Shift Towards Ultra-Clean, Modular, and Hybrid Energy Solutions

By Robert Kiyosaki
Energy Vault Holdings: A Strong Buy Amidst Rapid Growth and Strategic Transformation

Energy Vault Holdings: A Strong Buy Amidst Rapid Growth and Strategic Transformation

By Lisa Jing
DoubleVerify: Strong Growth, AI Opportunities, and Value Proposition

DoubleVerify: Strong Growth, AI Opportunities, and Value Proposition

By Fareed Zakaria
Harbor International Compounders Fund: Navigating Q1 2026 Performance and Future Outlook

Harbor International Compounders Fund: Navigating Q1 2026 Performance and Future Outlook

By David Rubenstein
BrandywineGLOBAL Global Opportunities Bond Fund Q1 2026 Commentary

BrandywineGLOBAL Global Opportunities Bond Fund Q1 2026 Commentary

By Strive Masiyiwa
BlackRock Inflation-Protected Bond Fund's Q1 2026 Performance Exceeds Expectations

BlackRock Inflation-Protected Bond Fund's Q1 2026 Performance Exceeds Expectations

By Michele Ferrero
Top Dental Insurance Providers for 2026: A Comprehensive Guide

Top Dental Insurance Providers for 2026: A Comprehensive Guide

By Robert Kiyosaki
Consumer Confidence: A Mixed Signal for Economic Outlook

Consumer Confidence: A Mixed Signal for Economic Outlook

By Fareed Zakaria
Sable Offshore Corp. Faces Dire Financial Straits Amidst Dilutive Financing Plan

Sable Offshore Corp. Faces Dire Financial Straits Amidst Dilutive Financing Plan

By Mariana Mazzucato
Ligand Pharmaceuticals: A Decade of Dominance and Strategic Evolution in Royalty Aggregation

Ligand Pharmaceuticals: A Decade of Dominance and Strategic Evolution in Royalty Aggregation

By Nouriel Roubini
Delta Air Lines: Q2 Expectations and Future Outlook

Delta Air Lines: Q2 Expectations and Future Outlook

By David Rubenstein
Nestlé Faces Critical Q2 2026: The Path to Growth Requires Volume, Not Just Price

Nestlé Faces Critical Q2 2026: The Path to Growth Requires Volume, Not Just Price

By Lisa Jing
ChipMOS Technologies: Capitalizing on the Memory Supercycle and AI Demand

ChipMOS Technologies: Capitalizing on the Memory Supercycle and AI Demand

By Nouriel Roubini